31/1294/2026 - Antiretroviral medications for HIV infection therapy

This tender, identified by reference 31/1294/2026, is specifically for the procurement of antiretroviral medications essential for the therapy of HIV infection. Antiretroviral therapy (ART) is a critical treatment regimen that suppresses the human immunodeficiency virus (HIV), preventing its replication and progression to AIDS. The objective of this tender is to ensure a consistent and reliable supply of these life-saving medications for patients undergoing treatment. The procurement will focus on acquiring high-quality antiretroviral drugs that meet international standards for efficacy and safety. Bidders will be evaluated based on their ability to provide these specialized pharmaceuticals, including aspects such as product availability, adherence to storage and handling requirements, competitive pricing, and timely delivery. Ensuring uninterrupted access to ART is paramount for managing HIV infection, improving patient health outcomes, and reducing transmission rates. This procurement is vital for public health initiatives related to HIV/AIDS treatment and management.

This is a supplies contract in the health and medical services and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 38,488.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.